Cargando…
Can We Harness Immune Responses to Improve Drug Treatment in Leishmaniasis?
Leishmaniasis is a vector-borne parasitic disease that has been neglected in priority for control and eradication of malaria, tuberculosis, and HIV/AIDS. Collectively, over one seventh of the world’s population is at risk of being infected with 0.7–1.2 million new infections reported annually. Clini...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409143/ https://www.ncbi.nlm.nih.gov/pubmed/32709117 http://dx.doi.org/10.3390/microorganisms8071069 |